Anxiety and depression down in 2021, but still elevated: CDC

National rates of anxiety and depression declined in the first half of 2021 but remain elevated compared to pre-pandemic levels, according to a CDC report published Oct. 5. 

Advertisement

The report is based on the ongoing Household Pulse Survey, a national online survey developed by the U.S. Census Bureau and the National Center for Health Statistics. The survey has polled a nationally representative sample of U.S. adults biweekly since April 23, 2020.

Based on survey responses, the CDC found average anxiety severity scores increased 13 percent between August and December 2020 before falling 26.8 percent between December 2020 and June 2021. CDC researchers reported a similar trend for depression rates. 

Despite the 2021 decreases, anxiety and depression rates were still higher than national estimates for 2019, according to the CDC. The relative increases and decreases in reported symptoms also “mirrored the national weekly number of new COVID-19 cases during the same period,” the agency said.

See the full report here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.